KRAS and colorectal carcinoma: NRAS‐mutation(+) CRC shows a high degree of malignancy compared with oncogene‐mutation(−) CRC 33, and there is no significant difference in prognosis of NRAS‐mutation(+) and KRAS‐mutation(+) CRC 23, 26, 33.